In August, Sputnik V, developed by the Gamaleya research institute, became the world's first registered vaccine against COVID-19. It is now in phase III post-registration clinical trials.

"Since the moment of Sputnik V state registration, over 117,000 doses of the vaccine have been released into civil circulation. Producers plan to produce over 2 million doses by the year end. Currently, immunization of high-risk groups, doctors and teachers is prioritized," Golikova told the coordination council of human rights commissioners.